[HTML][HTML] Awareness and current knowledge of breast cancer

M Akram, M Iqbal, M Daniyal, AU Khan - Biological research, 2017 - Springer
Breast cancer remains a worldwide public health dilemma and is currently the most common
tumour in the globe. Awareness of breast cancer, public attentiveness, and advancement in …

[HTML][HTML] High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

F Catanzariti, D Avendano, G Cicero… - Insights into …, 2021 - Springer
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …

Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancer

M Benvenuto, C Focaccetti, V Izzi, L Masuelli… - Seminars in Cancer …, 2021 - Elsevier
Breast cancer is both the most common type of cancer and the most frequent cause of
cancer mortality in women, mainly because of its heterogeneity and limited immunogenicity …

[HTML][HTML] Endocrine therapy for breast cancer: a model of hormonal manipulation

SJ Johnston, KL Cheung - Oncology and Therapy, 2018 - Springer
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …

Comprehensive analysis of PLKs expression and prognosis in breast cancer

W Jiawei, B Xiajun, S Tian, G Xuzheng, Z Zhenwang - Cancer Genetics, 2022 - Elsevier
Objective A thorough examination of PLKs in breast cancer, including their expression and
prognosis. Methods With the help of the Oncomine database, the transcript levels of PLKs in …

[HTML][HTML] Atypical ductal hyperplasia after vacuum-assisted breast biopsy: can we reduce the upgrade to breast cancer to an acceptable rate?

L Nicosia, A Latronico, F Addante, R De Santis… - Diagnostics, 2021 - mdpi.com
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal
hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum …

[HTML][HTML] Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography/digital …

CK Kuhl, A Keulers, K Strobel, H Schneider… - Breast Cancer …, 2018 - Springer
Background Breast magnetic resonance imaging (MRI) has been reported to frequently
result in false-positive diagnoses, limiting its positive predictive value (PPV). However, for …

Screening MRI in women at intermediate breast cancer risk: an update of the recent literature

M Bahl - Journal of Breast Imaging, 2022 - academic.oup.com
Guidelines issued by the American Cancer Society (ACS) in 2007 recommend neither for
nor against screening MRI in women at intermediate breast cancer risk (15%–20%) …

Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients

A Latronico, L Nicosia, A Faggian, F Abbate, S Penco… - The Breast, 2018 - Elsevier
Introduction Atypical ductal hyperplasia (ADH) is a high-risk benign lesion found in
approximately 1–10% of breast biopsies and associated with a variable incidence of …

[HTML][HTML] A risk stratification algorithm for lesions of uncertain malignant potential diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic …

P Clauser, P Kapetas, A Stöttinger, A Bumberger… - European Journal of …, 2021 - Elsevier
Purpose To investigate a risk stratification strategy for lesions of uncertain malignant
potential (B3) diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic …